EAMG supports EAACI/GA2LEN Allergy Schools on allergen-specific immunotherapy with an unrestricted educational grand.

The main purpose of the immunotherapy allergy schools is that participants bring back to their daily work in the laboratory or the clinic, knowledge about the importance of allergy and the underlying immunological conditions.

For qualifiyng physicians to optimally implement immunotherapy in their clinics insight into allergen extracts, different application forms and opportunities with combinations of different depot and adjuvant formulations is necessary.

Opportunities for establishment of quality assurance systems for specific diagnostic and treatment procedures is another important area of knowledge discussed at immunotherapy allergy school.

2010 Allergy School in Berlin, Germany

The First EAACI/GA2LEN Allergy School "Allergy and Immunotherapy" took place in DRK-Kliniken Westend in Berlin, Germany on 21-23 October 2010. 73 attendees from 28 countries participated in this school organized by Dr Jorg Kleine Tebbe with generous support from European Academy of Allergy and Clinical Immunology (EAACI) and the European Allergen Manufacturers Group (EAMG). The focus of the school was allergen specific immunotherapy, and experts from Europe and America shared their knowledge and experience in respiratory allergic diseases, specific diagnostic of allergy, basic immunology of allergy and mechanisms of specific immunotherapy, commercial allergen extracts, evidences for subcutaneous, sublingual specific immunotherapy, its safely in adults and children. Read More, Photos

2011 Allergy School in Saariselka, Finland

The aim of this Allergy School, held 31 March – 03 April 2011, is to educate and stimulate the social contacts between young physicians from all over Europe interested in diagnosis and treatment of allergic rhinoconjunctivitis, asthma and venom allergy applying allergen-specific immunotherapy (SIT) via subcutaneous (SCIT) and sublingual (SLIT) routes.

Upon completion of this course participants should be able to:
1. Understand the mechanisms of allergen-specific immunotherapy (SCIT and SLIT) with inhalants
2. Apply diagnostic tools, indications and contraindications to identify suitable subjects for SIT
3. Select preparations for SCIT and SLIT considering clinical documentation and individual factors
4. Manage allergic individuals with different approaches for SIT, considering safety and risk factors.

The course will include lectures which communicate basic and advanced knowledge (basic principles, clinical manifestations, indications for allergy testing, diagnostic methods, interpretation of results, novel diagnostic tests), interactive practical demonstration of skin tests and discussion of clinical cases. All sessions will be held in English. Read More, Final Programme

2012 Allergy School in Madrid, Spain

This school will be held in the spring of 2012.